Iron Supplementation Therapy in End-Stage Renal Disease Patients on Maintenance Hemodialysis

ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)

Volume 17, 3 Issues, 2017

Download PDF Flyer

Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Garry X. Shen
University of Manitoba
Winnipeg, MB

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Iron Supplementation Therapy in End-Stage Renal Disease Patients on Maintenance Hemodialysis

Cardiovascular & Hematological Disorders-Drug Targets, 13(3): 237-242.

Author(s): Masanori Shibata and Shinkichi Taniguchi.

Affiliation: 85 Kouden, Kunotsubo, Kita- Nagoya, Aichi, Japan 481-0041.


Iron supplementation therapy seems almost indispensable in adequate management of the patients with end - stage renal disease on maintenance hemodialysis, since at least one and a half grams iron is considered to be required per year to keep sufficient erythropoiesis. Iron supplementation in conjunction with erythropoietic-stimulating agents is widely carried out as a standard therapy. However, definite diagnosis of iron deficiency in hemodialysis patients is often difficult since serum ferritin levels increase frequently by various reasons including inflammation and malignancy. Although several guidelines to treat anemia of the hemodialysis patients have been proposed, they seem still insufficient and careful clinical observation is required in individual patient to avoid possible complications of iron overload. We, here, reassess the adequate iron supplementation therapy in those patients, and the necessity of new guideline employing recent advances including magnetic resonance imaging – based method (FerriScan) and hemoglobin content per each reticulocyte is also discussed.


Erythropoietic-stimulating agents, end-stage renal disease, ferritin, iron, hemodialysis, iron deficiency, iron supplementation, iron overload.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 13
Issue Number: 3
First Page: 237
Last Page: 242
Page Count: 6
DOI: 10.2174/1871529X1303140129155609
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science